Ebastin Orion

Ebastin Orion is an antihistamine that helps relieve allergy symptoms by blocking the effects of histamine in the body.

Form
tabletti, suussa hajoava
Strength
10 mg
Active Ingredient
Ebastine
Manufacturer
Orion Corporation

How to Use

Dosage

The usual dose for adults and children over 12 years is one 10 mg tablet once daily, but for severe symptoms, the dose can temporarily be increased to two 10 mg tablets daily.

Method

Place the tablet on your tongue where it will dissolve quickly; no water is needed, and take the tablet from the package with dry hands without crushing it, immediately after opening.

Important

Do not exceed 20 mg per day; if you have severe liver problems, do not exceed 10 mg per day.

Possible Side Effects

COMMON
  • headache
  • drowsiness
  • dry mouth
RARE
  • allergic reactions
  • nervousness
  • sleeplessness
  • dizziness
  • reduced sense of touch
  • taste disturbances
  • palpitations
  • abnormal heart rhythm
  • abdominal pain
  • vomiting
  • nausea
  • digestive problems
  • liver inflammation
  • gallbladder blockage (cholestasis)
  • abnormal liver function values
  • hives (urticaria)
  • skin rash
  • skin inflammation
  • menstrual disorders
  • swelling
  • weakness

Important Warnings

  • Do not use if you are allergic to ebastine or any other ingredients in this medicine.
  • Tell your doctor if you are taking antifungal medicines (e.g., ketoconazole, itraconazole), antibiotics (e.g., erythromycin), tuberculosis medicines (e.g., rifampicin), antidepressants, or heart rhythm medicines.
  • Talk to your doctor if you have severe liver problems.
  • Not for children under 12 years, as the effectiveness and safety of this medicine have not been confirmed in this age group.
  • Do not use during pregnancy or breastfeeding.
Show 1 more warnings
  • Since drowsiness and dizziness are possible side effects, check how the medicine affects you before driving or operating machinery.

Use in Elderly Patients

Category A

Suitable for older adults. (updated 19.9.2025)